United States
                    Environmental Protection
                    Agency
                      Research
                      and Development
                      (RD-689)
Air and
Radiation
(6203 J)
&EPA
                                                          January 1993
Respiratory   Health
Effects   of  Passive
Smoking
                    Fact  Sheet
    Summary

    The U.S. Environmental Protection Agency
    (EPA) has published a major assessment of
    the respiratory health risks of passive
    smoking (Respiratory Health Effects of
    Passive Smoking: Lung Cancer and Other
    Disorders; EPA/600/6-90/006F). The report
    concludes that exposure to environmental
    tobacco smoke (ETS) -- commonly known  as
    secondhand smoke — is responsible for
    approximately 3,000 lung cancer deaths each
    year in nonsmoking adults and impairs the
    respiratory health of hundreds of thousands
    of children.

    Background

    EPA studies of human exposure to air
    pollutants indicate that indoor levels of
    many pollutants often are significantly
    higher than outdoor levels.  These levels of
    indoor air pollutants are of particular
    concern because it is estimated that most
    people spend approximately 90 percent of
    their time indoors.
                    In recent years, comparative risk studies
                    performed by EPA and its Science Advisory
                    Board have consistently ranked indoor air
                    pollution among the top five
                    environmental risks to public health. EPA,
                    in close cooperation with other federal
                    agencies and the private sector, has begun a
                    concerted effort to better understand indoor
                    air pollution and to reduce peoples'
                    exposure to air pollutants in offices, homes,
                    schools and other indoor environments
                    where people live, work and play.

                    Tobacco smoking has long been recognized
                    as a major cause of death and disease,
                    responsible for an estimated 434,000 deaths
                    per year in the United States. Tobacco use
                    is known to cause lung cancer in humans,
                    and is a major risk factor for heart disease.

                    In recent years, there has been  concern that
                    non-smokers may also be at risk for some of
                    these health effects as a result of their
                    exposure ("passive smoking") to the smoke
                    exhaled by smokers and smoke given off by
                    the burning end of cigarettes.

-------
As part of its effort to address all types of
indoor air pollution, in 1988, EPA's Indoor
Air Division requested that EPA's Office of
Research and Development (ORD)
undertake an assessment of the respiratory
health effects of passive smoking. The
report was prepared by ORD's Office of
Health and Environmental Assessment.

The document has been  prepared under the
authority of Title IV of Superfund (The
Radon Gas and Indoor Air Quality Research
Act of 1986), which directs  EPA to conduct
research and disseminate information  on
all aspects of indoor air quality.

Public and Scientific Reviews

A draft of this assessment was released for
public review in June 1990. In December
1990,  EPA's Science Advisory Board, a
committee  of independent scientists,
conducted a review  of the draft report and
submitted its comments  to the EPA
Administrator in  April 1991. In its
comments, the SAB's Indoor Air
Quality/Total Human Exposure Committee
concurred with the  primary findings of the
report, but made a number of
recommendations for strengthening it.

Incorporating these recommendations, the
Agency again transmitted a new draft to the
SAB in May of 1992 for a second review.
Following a July 1992 meeting, the  SAB
panel  endorsed the major conclusions of
the report, including its  unanimous
endorsement of the classification of
environmental  tobacco smoke (ETS) as a
Group A (known human)  carcinogen.

EPA also received and reviewed more  than
100 comments from the  public, and
integrated appropriate revisions into the
final risk assessment.
Major Conclusions

Based on the weight of the available
scientific evidence, EPA has concluded that
the widespread exposure to environmental
tobacco smoke in the U.S. presents a serious
and substantial public health risk.

In adults:

• ETS is a human lung carcinogen,
responsible for approximately 3,000 lung
cancer deaths annually in U.S. nonsmokers.
ETS has been  classified as a Group A
carcinogen under EPA's carcinogen
assessment guidelines. This classification is
reserved for those compounds or mixtures
which  have been shown to cause cancer in
humans, based on studies in human
populations.

In children:

• ETS exposure increases the risk of lower
respiratory tract infections such as
bronchitis and pneumonia.  EPA estimates
that between 150,000 and 300,000 of these
cases annually in infants and young
children up to 18 months of age are
attributable to exposure to ETS. Of these,
between 7,500  and 15,000 will  result in
hospitalization.

• ETS exposure increases the  prevalence of
fluid in the middle ear, a sign of chronic
middle ear disease.

• ETS exposure in children irritates the
upper respiratory tract and is associated
with a small but significant reduction in
lung function.

• ETS exposure increases the  frequency of
episodes and severity of symptoms in
asthmatic children. The report estimates

-------
that 200,000 to 1,000,000 asthmatic children
have their condition worsened by exposure
to environmental tobacco smoke.

• ETS exposure is a risk factor for new cases
of asthma in children who have not
previously displayed symptoms.

Scope of the Report

In 1986, the National Research Council
(NRC) and the U.S.  Surgeon General
independently assessed the health effects of
exposure to ETS.  Both of these reports
concluded that ETS  can cause lung cancer i n
adult non-smokers  and that children of
parents  who smoke have increased
frequency of respiratory symptoms and
lower respiratory tract infections. The EPA
scientific assessment builds on these reports
and is based on a thorough  review of all  of
the studies in the available  literature.

Since 1986, the number of studies which
examine these issues in human
populations  has  more than doubled,
resulting in a larger database with which to
conduct a comprehensive assessment of  the
potential effects which passive smoking
may have on the respiratory health of
adults as well as children.

Because only a very small number of
studies  on the possible association between
exposure to secondhand smoke and  heart
disease  and other cancers existed in the
scientific literature at the time this
assessment was first undertaken, EPA has
not conducted an assessment  of the possible
association of heart  disease  and passive
smoking.  EPA is considering whether such
an assessment should be undertaken in the
future, but has no plans to do so at this
time.
Scientific Approach

EPA reached its conclusions concerning the
potential for ETS to act as a human
carcinogen based on an analysis of all of the
available data, including more than 30
epidemiologic (human) studies looking
specifically at passive smoking as well as
information  on active or direct smoking. In
addition, EPA considered animal  data,
biological measurements of human uptake
of tobacco smoke components and other
available data. The conclusions were based
on what is commonly known as the total
"weight-of-evidence" rather than on any
one study or type of study.

The finding that ETS should be classified as
a Group A carcinogen  is based on the
conclusive evidence of the dose-related
lung carcinogenicity of mainstream smoke
in active smokers and the similarities of
mainstream and sidestream smoke given
off by the burning end of the cigarette. The
finding is bolstered by the statistically
significant exposure-related increase in lung
cancer in nonsmoking spouses of smokers
which is found in an analysis of more than
30 epidemiology studies that examined the
association between secondhand smoke and
lung cancer.
          i
The weight-of-evidence analysis for the
noncancer respiratory effects in children is
based primarily on a review of more than
100 studies, including 50 recent
epidemiology studies of children  whose
parents  smoke.

Beyond the Risk Assessment

Although EPA does not have any
regulatory authority for controlling ETS, the

-------
Agency expects this report to be of value to
other health professionals and
policymakers in taking appropriate steps to
minimize peoples' exposure to tobacco
smoke  in indoor environments.

In cooperation with other government
agencies, EPA will carry out an education
and outreach program over the next  two
years to inform the public and policy
makers on what to do to reduce the health
risks of ETS as well as other indoor air
pollutants.

For Further Information

A limited number of copies of the complete
report  can be obtained free of charge  from:

Center for Environmental Research
Information (CERI)
U.S.  EPA
26 W. Martin Luther King Drive
Cincinnati, OH 45268
Telephone:  513-569-7562
Fax:  513-569-7566

Ordering Number: EPA/600/6-90/006F
             or
U.S. Environmental Protection Agency
Indoor Air Quality Information
Clearinghouse (IAQ INFO)
P.O. Box 37133
Washington D.C. 20013-7133
Telephone: 1-800-438-4318
Fax: 301-588-3408

A number of government agencies can
provide additional information addressing
the health risks of environmental  tobacco
smoke.  These include:
Office on Smoking and Health/Centers for
Disease Control
Center for Chronic Disease Prevention and
Health Promotion
Mail Stop K-50, 4770 Buford Highway
Atlanta, GA 30341

National  Cancer Institute
Building  31, Room 10A24
Bethesda, MD 20892
1-800-4-CANCER

The National Heart, Lung, and Blood
Institute
Information Center
4733 Bethesda Avenue, Suite 530
Bethesda, MD 20814

National  Institute for Occupational Safety
and Health
4676 Columbia Parkway
Cincinnati, Ohio 45226-1998
1-800-35-NIOSH

-------